SLSN
SOLESENCE, INC.
NASDAQ · Consumer Defensive · Household & Personal Products · US
$0.85
−1.50%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 55.4M | 62.1M | 52.3M | 37.3M | 37.3M |
| Cost of Revenue | 40.5M | 46.0M | 36.2M | 29.5M | 29.0M |
| Gross Profit | 14.9M | 16.0M | 16.2M | 7.8M | 8.4M |
| Operating Expenses | |||||
| R&D Expense | 4.1M | 4.1M | 3.8M | 3.8M | 3.0M |
| SG&A Expense | 11.8M | 10.4M | 7.2M | 7.5M | 7.6M |
| General & Admin Expense | — | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 15.8M | 14.5M | 11.1M | 11.4M | 10.6M |
| Cost and Expenses | 56.3M | 60.5M | 47.2M | 40.8M | 39.6M |
| Operating Income (EBIT) | (978.0K) | 1.6M | 5.1M | (3.5M) | (2.3M) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 1.2M | 931.0K | 670.0K | 838.0K | 382.0K |
| Net Interest Income | (1.2M) | (931.0K) | (670.0K) | (838.0K) | (382.0K) |
| Other Non-Op Income/Expense | (1.2M) | 291.0K | (670.0K) | (838.0K) | (382.0K) |
| Non-Operating Income (excl Interest) | 11.0K | (1.2M) | — | — | — |
| EBT (Pre-Tax Income) | (2.2M) | 1.9M | 4.5M | (4.4M) | (2.6M) |
| Income Tax Expense | (317.0K) | 73.0K | 227.0K | 6.0K | (17.0K) |
| Bottom Line | |||||
| Net Income | (1.9M) | 1.8M | 4.2M | (4.4M) | (2.6M) |
| Earnings from Cont. Ops | (1.9M) | 1.8M | 4.2M | (4.4M) | (2.6M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (1.9M) | 1.8M | 4.2M | (4.4M) | (2.6M) |
| Per Share | |||||
| Basic EPS | ($0.03) | $0.03 | $0.07 | ($0.09) | ($0.05) |
| Diluted EPS | ($0.03) | $0.02 | $0.07 | ($0.09) | ($0.05) |
| Revenue Per Share | $0.78 | $0.88 | $0.84 | $0.75 | $0.76 |
| Shares | |||||
| Basic Shares Outstanding | 70.6M | 70.3M | 62.4M | 49.6M | 49.1M |
| Diluted Shares Outstanding | 70.6M | 72.6M | 65.0M | 49.6M | 49.1M |
| Profitability Metrics | |||||
| EBITDA | 91.0K | 3.7M | 6.1M | (2.8M) | (1.7M) |
| D&A | 1.1M | 897.0K | 928.0K | 742.0K | 567.0K |
| EBIT | (989.0K) | 2.8M | 5.1M | (3.5M) | (2.3M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026